Stress echocardiography causes stress cardiomyopathy: A very rare complication should be reminded  by Takagi, Atsushi et al.
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ditorialtress  echocardiography  causes  stress  cardiomyopathy:  A  very  rare  complication
hould  be  reminded
who demonstrate anxiety or agony during DSE by gentle explana-
tion. Moreover, we should remind ourselves of the possibility of
TCM even during the recovery period after DSE.
Table 1
Reported cases of takotsubo cardiomyopathy following DOB stress.
Author Year Age Gender Peak DOB Atropine Phase
Silberbauer 2008 75 Female 30 0.5 mg  Peakeywords:
akotsubo cardiomyopathy
obutamine
tress
chocardiography
Dobutamine stress echocardiography (DSE) is widely used for
etection and risk stratiﬁcation of patients with coronary artery
iseases [1]. Recent advances both in stress protocol and digital
maging allow us more accurate assessment using DSE [2]. Dobu-
amine stress has been regarded as safe with few adverse events.
eleijnse reported major complications of dobuamine–atropine
tress echocardiography in 116 patients or 0.2% among 55,071
atients [3]. The most common arrhythmic complication is atrial
brillation. In a recent large cohort with 11,806 patients, 0.5% of
atients developed atrial ﬁbrillation which terminated within a
ay in most of the cases without serious cardiac events [4]. Even
hough the incidence is not frequent, complications may  result in a
erious morbidity or mortality. The most life-threatening compli-
ation of DSE is ventricular tachycardia which occurred in 0.15% of
atients.
The present article written by Ho et al. [5] reported a case of
akotsubo cardiomyopathy (TCM) following DSE. TCM or transient
pical ballooning is known as a stress-induced acute myopathy
hich is most likely to affect elder female patients as in the
resent case [6]. Psychiatric as well as physical stresses are the
ause of TCM. Medical or dental procedures can also trigger this
yndrome [7]. TCM mimics the symptoms and STT ﬁndings of
T elevation acute myocardial infarction. Compared to anterior
cute myocardial infarction, TCM is associated with ST depres-
ion in aVR lead and lack of ST elevation in V1 lead [8]. Even
hough, the difference in the distribution of ST elevation, the most
peciﬁc ﬁnding of TCM is the wall motion abnormality without
oronary stenosis. About 80% of TCM develops apical balloon-
ng with hyperkinetic motion of basal walls. However, several
atterns of wall motion abnormality can be seen in TCM, such
s biventricular, midventricular, and basal wall of left ventricle
9].
Several cases with TCM following DSE have already been
eported (Table 1) [5,10–13]. All of the cases were elder females.
DOI of original article: http://dx.doi.org/10.1016/j.jccase.2012.03.003.
878-5409/$ – see front matter © 2012 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jccase.2012.06.014Most of the patients developed TCM during the peak dobutamine
at a standard dose, with or without atropine. Management of TCM
is rather supportive when the hemodynamics show stability. Beta
blockers could be considered if left ventricular outﬂow obstruction
occurs. However, physicians should be cautious about the possibil-
ity of multivessel spasm before starting beta blockers in Japanese
patients.
It is known that catecholamine levels are elevated in patients
with TCM, suggesting increased synthesis or reuptake and
decreased removal of catecholamines [14]. However, it is not
certain that exogenous catecholamine infusion causes TCM. A
clue might be in the fact that some patients developed TCM
at the recovery period of DSE despite showing normal wall
motion during peak stress such as in the present case [15].
It is also known that neuropsychiatric complications can be
seen following DSE. Neuropsychiatric symptoms include confu-
sion, memory disturbance, and disorientation, which occurred
in 7.1% of patients within 24 h after DSE [16]. Not the dose
of dobutamine but atropine use was  the strongest predictor
of neuropsychiatric symptoms. Underlying neuropsychiatric dis-
ease was  also a predictor of these complications after DSE.
These results suggested that patient’s anxiety and agony dur-
ing DSE might be a trigger of neuropsychiatric reaction following
DSE.
What should we do to avoid TCM following DSE? Probably we
should pay much attention to choose the stress methods and pro-
tocol after assessing the patient’s characteristics, especially in the
case of elderly ladies. We  should also take much care of patientsCherian 2008 85 Female 40 No Peak
Margey 2009 61 Female 40 No Peak
Mosley 2010 50 Female 30 0.5 mg  Peak
74 Female 40 0.25 mg  Peak
Shah 2011 85 Female 30 No Recovery
Ho 2012 83 Female 40 0.5 mg  Recovery
DOB, dobutamine (mcg/kg/min).
vier Ltd. All rights reserved.
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